This review presents an analysis of the literature on behavioral effects of developmental exposure to nicotine, as assessed in rodent models that mimic the consequences for human offspring of maternal cigarette smoking. Despite the frequency of reports of low birth weight, hyperactivity, cognitive defi cits, and psychiatric problems, inconsistencies exist in both the clinical and experimental literature. Confounding socioeconomic and other demographic variables may account for discrepancies in clinical reports, and the choice of developmental exposure period and the method of nicotine administration may explain differences in experimental outcomes. Analysis of a number of variables (e.g., physical, behavioral, and cognitive) shows that fetal exposure to nicotine does not consistently cause growth retardation or decreased birth weight, nor reliably affect motor activity. But combined preand neonatal exposure is likely to result in delayed refl ex development, global impairments in learning and memory, and an increased incidence of symptoms that model psychiatric illness. There is also support for increased self-administration of nicotine and other drugs of abuse in animals exposed developmentally to nicotine, as well as potent effects on offspring responses to drug challenges. Unlike reports in the clinical literature, sexually dimorphic effects were not evident in most animal models. Possible neuroanatomical and cholinergic mechanisms responsible for behavioral changes are briefl y discussed. Statistical and design considerations are provided to increase the translational value of this research and, most importantly, enhance the replicability of reported fi ndings.
Introduction

T
here is little doubt that maternal smoking during pregnancy is one of the most preventable causes of injury to the developing organism. Unfortunately, the incidence of such exposure is high and appears to be growing worldwide (Shafey et al. 2009 ). Exact estimates of exposure levels are problematic as women are known to deliberately underreport their smoking during pregnancy-reports from the United States, Scotland, and New Zealand estimate 25% underreporting in these countries (Britton et al. 2004; Ford et al. 1996; Tong et al. 2010) . Consequently, although the reported incidence of smoking during pregnancy in the United States has been dropping, current estimates that approximately 10% of pregnancies involve maternal smoking (Bruin et al. 2010; CDC 2004 CDC , 2009a DHHS 1998; Somm et al. 2009 ) should probably be adjusted upward by at least 3 percentage points, to around 13% or so. Similar incidences are reported in Europe (Cnattingius 2004) and Japan (Suzuki et al. 2010) .
Although in many less-developed countries there is a staggering epidemic of male smoking (e.g., in China some 60% of males smoke; Shafey et al. 2009 ), the percentage of women who smoke is much smaller-only about 9%, compared to around 22% in the developed world (Bloch et al. 2008; Shafey et al. 2009 ). It is thus likely that at least 5% of pregnancies worldwide are exposed to cigarette smoke and that, as happened in the developed world, this percentage will continue to rise.
The looming epidemic of maternal smoking during pregnancy requires careful scientifi c assessment of levels and types of damage, followed by the widest possible dissemination of this information. Unfortunately, determination of the consequences of maternal smoking is hampered by a very high level of confounding. Mothers who smoke are different in many ways from those who do not, and many of these differences are known to carry their own developmental risks. In the United States, for example, mothers who smoke are more likely to be poorer, younger, less educated, and single parents than mothers who do not smoke (Boutwell et al. 2010) . Adjustment for these confounds can substantially reduce or even zero out the estimated harm done by smoking per se, as we shall demonstrate below.
Physical, Behavioral, and Cognitive Effects in Humans
Physical Impacts
It has been over 50 years since the fi rst report of the association between tobacco smoking during pregnancy and decreased body weight in the fetus (Simpson 1957) . Shortly thereafter the 1964 US Surgeon General's report stated that women who smoke cigarettes during pregnancy tend to have babies of lower birth weight (Carmines et al. 2003) . Epidemiological investigations have since established a relatively consistent association between use of tobacco products by pregnant women and the increased risk of their infants' low birth weight and small size. In many studies, these effects cannot be explained by confounding factors such as constitutional, sociodemographic, and lifestyle variables (Bruin et al. 2010; Ernst et al. 2001; Paulson et al. 1994) , although other investigations have implicated demographic variables (Toschke et al. , 2003 von Kries et al. 2008) .
Reported reductions in body weight range from 2% to 10% in large-scale studies from a host of developed nations (Blake et al. 2000; Fergusson et al. 1979; Gilman et al. 2008; Haddow et al. 1987; Haug et al. 2000; Matsubara et al. 2000) , and a meta-analysis of 895 studies identifi ed smoking as the single greatest cause of low birth weight in developed countries (Kramer 1987) . Size reductions are not restricted to body weight: height, size of long bones (especially in the legs), and head circumference also appear to be reduced in children exposed to smoking during gestation Kallen 2000; Lampl et al. 2003 ; Leary et al. 2006; Rantakallio 1983; Roza 2007; Vik 1996; Villalbi et al. 2007; von Kries et al. 2002 von Kries et al. , 2008 .
Low birth weight may be a harbinger of later medical problems in children exposed in utero to maternal smoking. For example, although children of mothers who smoked during pregnancy weighed less at birth, their weight subsequently equaled or exceeded that of their nonsmoking counterparts within the fi rst 5 months after birth. These children also exhibited an increased risk of being overweight as early as 3 years of age in some populations, culminating in persistent overweight throughout adolescence, especially in females (Adams et al. 2005; Chen et al. 2005; Dubois and Girard 2006; Dunn et al. 1976) .
Data from retrospective and prospective studies appear to confi rm a direct effect of maternal smoking during pregnancy on obesity (with its attendant health consequences) in adolescent and adult offspring (Adams et al. 2005; Chen et al. 2006; Dubois and Girard 2006; Fried et al. 1999 Fried et al. , 2001 Hill et al. 2005; Leary et al. 2006; Oken et al. 2005; Toschke et al. 2002 Toschke et al. , 2003 Vik et al. 1996; von Kries et al. 2002 von Kries et al. , 2008 . Although smoking at any time during pregnancy has been associated with higher offspring body mass index (Leary et al. 2006) , the risk may be greater from cigarette smoking during the fi rst trimester (Toschke et al. 2003) . Some studies, however, have reported results to the contrary (Fogelman and Manor 1988; Fried et al. 1999 Fried et al. , 2001 ; Oken et al. 2005) , and the evidence for a direct, long-term effect on growth is inconsistent (MacArthur et al. 2001; Toschke et al. 2003) .
Cognitive Impacts
Cognitive defi cits may also result from gestational exposure to cigarette smoke-studies have identifi ed long-term intellectual impairment and subtle behavioral abnormalities.
Human newborns show defi cits in responsiveness to auditory stimuli, increased irritability, and impairments in learning simple operant tasks (Ernst et al. 2001; Eskenazi and Castorina 1999; Martin et al. 1977; McCartney et al. 1994) . Differences in information processing between nicotine-exposed and nonexposed infants suggest alterations in early cognitive processes (Levin et al. 1993) . Defi ciencies in intellectual development; slow reading attainment; poor social adjustment in school; impaired performance on psychological and standardized intelligence tests, vigilance tasks, and tests of block design and vocabulary; and an increased incidence of attention defi cit disorder have all been reported for children prenatally exposed to cigarette smoke. Some studies suggest that cognitive defi cits associated with gestational exposure to tobacco continue into late childhood and adolescence, with the offspring of smokers displaying higher rates of attention defi cits and impaired learning and memory capabilities (Ernst et al. 2001; Fried et al. 1998 Fried et al. , 2003 Niaura et al. 2001) .
However, the type, severity, and duration of these cognitive and perceptual problems differ (Butler and Goldstein 1973; Meyer and Carr 1987; Naeye and Peters 1984) , and results to the contrary have been reported (Fogelman 1980) . Furthermore, the degree to which these children return to normal levels of intellectual functioning is not consistent.
Numerous studies have reported that maternal smoking during pregnancy results in a reduction of approximately one-half a standard deviation in IQ, particularly in verbal abilities (Batstra et al. 2003; Watkinson 1990, 2000; Fried et al. 1992 Fried et al. , 1997 Fried et al. , 1998 Fried et al. , 2003 Fogelman 1980; Makin et al. 1991; Mortensen 2005; Naeye and Peters 1984; O'Callaghan et al. 2006 O'Callaghan et al. , 2009 Olds et al. 1994a,b) . However, these fi ndings are confounded with other characteristics of mothers who smoke. Statistical adjustment for these confounds in some studies has suggested that they, rather than the cigarette smoking, may fully explain the reported cognitive defi cits (Alati et al. 2008; Baghurst et al. 1992; Batty et al. 2006; Breslau et al. 2005; Fergusson and Lloyd 1991; Gilman et al. 2008; Lambe et al. 2006; McGee and Stanton 1994; Niemela and Jarvenpaa 1996; Trasti et al. 1999) .
In light of these confl icting fi ndings, a causal link between maternal gestational smoking and offspring cognitive abilities in humans should be considered controversial.
Social Impacts
Clinical and epidemiological studies indicate that children and adolescents who were exposed to nicotine in utero have an increased risk for conduct disorders and adult criminality, substance abuse, major depression, and attention defi cit hyperactivity disorder (ADHD 1 ), as well as defi ciencies in emotional development, that are more pronounced in males than females (Ernst et al. 2001; Fergusson et al. 1998; Niaura et al. 2001) .
Large-scale studies from around the world have reported a fi rm statistical link between maternal smoking and ADHD in offspring (Biederman et al. 2009; Braun et al 2006; D'Onofrio et al. 2008; Indredavik et al. 2007; Kotimaa et al. 2003; Langley et al. 2007; Mick et al. 2002; Milberger et al. 1996 Milberger et al. , 1998 Naeye and Peters 1984; Thapar et al. 2003) . However, confounding factors that involve maternal characteristics cloud the evidence for a causal link between ADHD and smoking exposure (Hill et al. 2000; Huijbregts et al. 2007 ; Knopik et al. 2005; Lindblad and Hjern 2010) .
Similar confounds exist for the relationship between gestational exposure to cigarette smoke and (1) juvenile conduct disorder and adult criminality (Boutwell et al. 2010; Braun et al. 2008; Brennan et al. 1999; Gatzke-Kopp and Beauchaine 2007; Huijbregts et al. 2007; Indredavik et al. 2007; Langley et al. 2007; Wakschlag et al. 1997 Wakschlag et al. , 2000 Wakschlag et al. , 2006 Weissman et al. 1999) , (2) offspring drug abuse (especially smoking) (Buka et al. 2003; Cornelius et al. 2005; Kandel et al. 1994; O'Callaghan et al. 2009; Porath and Fried 2005; Roberts et al. 2005) , and (3) other psychiatric disorders (Ekblad et al. 2010; Dombrowski et al. 2005; Williams et al. 1998) .
Again, the direct relationship of these disorders to maternal smoking during pregnancy is brought into question when adjustments are made for maternal confounds (Boutwell and Beaver 2010; Cornelius et al. 2005; D'Onofrio et al. 2008; Kandel and Udry 1999; Kardia et al. 2003; Koren 1999; Maughan et al. 2001; Rantakallio et al. 1992; Roza et al. 2007; Silberg et al. 2003) . Moreover, the existence of a high comorbidity between nicotine addiction and other neuropsychiatric conditions in the offspring adds to the diffi culty of establishing a direct causal link to maternal nicotine consumption (Ernst et al. 2001 ).
Importance of Animal Research
It is clear from the foregoing discussions that many confounding factors complicate the study in humans of the impacts of maternal smoking, and statistical adjustment for these factors removes many of the effects attributed to developmental exposure to cigarette smoke. The question of causation can be resolved only by eliminating or controlling the confounding variables and determining actual mechanisms of reported smoking-induced outcomes. Such research is diffi cult, indeed often impossible in humans, so animal models of ontogenetic exposure to cigarette smoke and nicotine have been developed. Only animal experimentation can fully control for these confounds and clearly identify neural mechanisms linking smoking to any real effects.
Animal studies enable accurate measurement of the characteristics of the exposure itself, control of the dose and window of developmental exposure, and detailed evaluation of the effects of early exposure (Girard et al. 2001) . Extensive assessment of physiological, anatomical, neurochemical, and behavioral disturbances in animals provides insight into the severity of prenatal nicotine/tobacco exposure. The shorter life of most experimental animals permits assessment of the long-term consequences of developmental nicotine exposure and of the persistence of these effects throughout the lifespan (Huang et al. 2007; Vaglenova et al. 2004) . Most importantly, animal models provide a conceptual framework for understanding the causes of clinical disorders. They yield valuable insight into the mechanisms underlying nicotine-induced pathophysiology and suggest a causal relationship between developmental nicotine exposure and structural and functional impairments in the central nervous system (CNS 1 ) (Dwyer et al. 2009; Slotkin 1998; Thomas et al. 2000) .
One further issue also requires animal experimentation. Cigarette smoke contains over 4,000 ingredients, hundreds of which may be potential teratogens. Even in animal models it is diffi cult to identify the various roles of such smoke constituents. Research to date has primarily focused on one constituent of cigarette smoke, nicotine. Nicotine is the main stimulant and addictive alkaloid in tobacco and it has been implicated as a causative factor in the intrauterine growth retardation associated with smoking during pregnancy (Somm et al. 2009 ). Although tobacco smoke contains other active compounds, such as carbon monoxide and the ingredients in tobacco tar, animal studies have provided compelling evidence that nicotine is the single most important factor in triggering negative effects on neurodevelopment (Ernst et al. 2001; Slotkin 2008) .
Although animal models can provide signifi cant amounts of information on neurobiological mechanisms in systems relevant to humans, fi nding the appropriate model can be challenging. Each species has advantages and disadvantages with respect to nicotine's pharmacokinetic parameters and the animal's receptor and neurotransmitter systems and sensitivity to nicotine. Moreover, there is diffi culty in relating neurobehavioral defi cits reported in animal studies to changes in human behavior, despite well-characterized models of complex behaviors in some species. Matta and colleagues (2007) provide an exhaustive review of these and other factors involved in the choice of an appropriate model.
The primary subject of this review is the effects of developmental exposure to nicotine in animals, with secondary discussion of other constituents of tobacco smoke that may infl uence developmental outcomes in exposed humans. The focus is on animal analogues of the physical, cognitive, and behavioral effects that refl ect the most frequently reported consequences of maternal smoking during pregnancy on human offspring. tobacco with respect to developmental period and route of administration of the drug. These choices depend in turn on the research hypothesis being tested as well as practical considerations (e.g., the animal species chosen and familiarity with and availability of assessment tools). Differences in outcomes refl ect in part the specifi c neural susceptibilities of each development stage as well as the pharmacokinetic and -dynamic properties of various routes of nicotine administration. However, all models can be used to examine the risks associated with developmental nicotine exposure and the neuroanatomical and neuro-/biochemical alterations underlying associated functional defi cits.
Developmental Exposure
The CNS can develop throughout the lifespan, but prenatal, neonatal, or pre-and postnatal exposure periods are the focus of this article. The conservation of the timing and sequence of early events in brain development across mammalian species increases the probability that the study of neurotoxicant exposure during these periods will enhance understanding of their effects on the ontogeny of the human nervous system and subsequent behavior (Clancy et al. 2007 ). Nonetheless, animal models have potential confounds, and none fully models human prenatal tobacco smoke exposure (Dwyer et al. 2009 ).
Prenatal Exposure
Although rats and mice are altricial species, they are born at an earlier stage of brain development than humans (see Figure 1 in Barr et al. 2011) . Prenatal exposure to nicotine during the 21-to 22½-day gestational period in the rat models tobacco exposure during the fi rst 2 trimesters of human gestation, not the full-term infant.
Notwithstanding the different rates of maturation, the brain contains certain core elements and developmental sequences that are universally shared across mammalian species, giving rise to strong parallels in their morphological development. These correlations between periods of neural development in rodents and humans have validated the use of animal models to study human brain maturation (Bayer et al. 1993; Clancy et al. 2007; Dwyer et al. 2009; Quinn 2005) .
In both humans and rats, most neuronal cell groups develop and early synaptogenesis occurs during the prenatal period (Bayer et al. 1993) . Moreover, it is only through gestational administration that investigators can evaluate the role of changes in the fetal-maternal unit in mediating the effects of tobacco/nicotine exposure on the developing organism. Gestational exposure paradigms include the entire prenatal period or selected portions designed to target the "birthdays" of cells in particular brain regions.
Neonatal Exposure
The fi rst 6 to 12 postnatal days of life in the rat are approximately comparable to the third trimester of human gestation (Barr et al. 2011; Dobbing 1971; Quinn 2005) . This developmental period is characterized by rapid brain growth that includes dendritic arborization, axonal growth, peak synaptogenesis, gliogenesis, and maturation of neurotransmission. Neurogenesis in late-developing structures such as the hippocampus and cerebellum is just beginning. This period of brain plasticity is especially sensitive to environmental factors such as stress, malnutrition, and drugs (Dwyer et al. 2009 ).
Animal models use both lactational and direct exposure paradigms. Exposure through suckling provides a natural route of nicotine administration and is primarily a continuation of prenatal maternal exposure, although there is one report of de novo postnatal treatment of the dam . However, nicotine reduces milk secretion in lactating rat dams, confounding nutritional and nicotine effects (Peters and Tang 1982) .
Direct exposure-via subcutaneous (s.c. 1 ) injections (Segarra and Strand 1989) , oral gavage (Gilbertson and Barron 2005; Huang et al. 2006) , or gastrostomy tubes (Girard et al. 2001; Thomas et al. 2000) -affords the opportunity to study the effects of drugs directly on offspring development, independent of maternal physiology, and to determine the consequences of nicotine on developing parameters (Girard et al. 2001 ). However, s.c. injections are stressful, making it diffi cult to separate drug effects from the stress of injection, and nicotine-induced changes in the pups may alter maternal behavior when they are returned to the litter.
The use of the gastrostomy tube for the neonatal delivery of nicotine requires an artifi cial rearing technique that isolates the pup from the litter. There is an extensive literature detailing the neurobehavioral changes that result from maternal separation. In rats, postnatal maternal separation can produce lasting increases in anxiety-like behaviors, exaggerated responses to psychostimulants, voluntary alcohol consumption, and stressor reactivity, together with alterations in brain neurotransmitter systems implicated in emotionality, including corticotropin-releasing factor, serotonin, norepinephrine, and glutamate (for recent reviews, Holmes et al. 2004; Moffett et al. 2007 ). Many of these mirror the effects reported for neonatal nicotine exposure.
Pre-and Neonatal Exposure
The combined exposure paradigm is thought to refl ect the human situation in which women continue to smoke after childbirth. It has also been used to investigate whether nicotine withdrawal during lactation affected developmental measures in the offspring (Vaglenova et al. 2004) . Moreover, to model the third trimester of human growth, rat pups must be exposed to nicotine postnatally, up through at least postnatal day (PND 1 ) 9 or 10, the period encompassing the "brain growth spurt" (Dobbing and Sands 1979; Thomas et al. 2000) .
Routes of Nicotine Administration
A major consideration in designing animal studies to determine the effect of nicotine on the developing organism is the method of drug administration. Matta and colleagues (2007) reviewed the impact of various routes of administration of nicotine on pharmacokinetic and pharmacodynamic parameters in several species; we limit our review to the impact on the pregnant rodent and developing offspring.
Injection
A number of studies in rats have used either s.c. (Ajarem and Ahmad 1998; Bertolini et al. 1982; Genedani et al. 1983; Johns et al. 1982; Martin and Becker 1971; Peters and Ngan 1982; Yanai et al. 1992) or intraperitoneal (i.p. 1 ) Sabherwal 1994, 1998; Segarra and Strand 1989) injections of nicotine delivered 1 to 3 times a day to the pregnant dam. Multiple injections are advantageous as they enable control of the dose and time of administration (Matta et al. 2007 ) and may provide a more equitable drug titer over a 24-hour period than a single daily injection (Martin and Becker 1971) . But multiple injections entail repeated stress for the dam. Activation of the stress-response system has been shown to induce neurochemical and behavioral abnormalities in offspring because of the well-known impact of maternal stress on brain development and behavior (Weinstock 2007) . Moreover, control groups cannot control for the interaction between stress and nicotine (Paz et al. 2007) .
Both s.c. and i.p. injections produce rapid absorption and a short duration of action, and episodic drug delivery produces less penetration into the fetal compartment than continuous delivery (Slotkin 1998) . Each method results in a sudden spike in the concentration of nicotine in the maternal plasma and fetus (Eppolito and Smith 2006; Paz et al. 2007 ), but i.p.-administered nicotine undergoes a considerable fi rst-pass metabolism, which reduces the relative dose exposure and thus maternal and fetal blood levels (Matta et al. 2007 ). Furthermore, episodic peaks can constrict placental vasculature and result in fetal hypoxia and ischemia, potentially confounding effects (Abdel-Rahman et al. 2005; Eppolito and Smith 2006; Huang et al. 2007; Murrin et al. 1987; Paulson et al. 1994; Roy and Sabherwal 1998; Slotkin 1998; Yanai et al. 1992) .
It is diffi cult to separate potential adverse consequences of the indirect effects described above from those that refl ect direct action on developing cells (Paulson et al. 1994; Zahalka et al. 1992) . But episodic hypoxia and spikes in nicotine plasma concentration are features common to heavy cigarette smoking in humans (Roy and Sabherwal 1998) , and episodic intravenous (i.v.) administration of nicotine is similarly thought to closely resemble human smoking behavior (LeSage et al. 2006) .
Osmotic Minipump
Exposure to nicotine via the osmotic minipump (OMP 1 ) provides a slow chronic release that results in relatively steadystate plasma concentrations similar to those that human smokers achieve and defend (Abdel-Rahman et al. 2005; Eppolito and Smith 2006) . With the OMP, there is also an excellent consistency from animal to animal in plasma levels of nicotine's major metabolite cotinine, as well as a direct linear correlation between the amount of nicotine delivered and the plasma levels of nicotine and cotinine (Eppolito and Smith 2006; Murrin et al. 1987) .
By eliminating the spike in plasma nicotine levels, the OMP model permits the clear identifi cation of nicotine as a contributor to the reported effects of prenatal nicotine exposure without the confounding factors of hypoxia and ischemia or stress from repeated injections (Abdel-Rahman et al. 2005; Slotkin et al. 1991) . Separating nicotine from the other variables and/or constituents of tobacco smoke is of paramount importance, given the therapeutic use of nicotine replacement therapy for smoking cessation, even during pregnancy (Roy et al. 2002) . If nicotine itself is injurious to the fetal brain, then nicotine substitution is unlikely to eliminate all of the deleterious effects of maternal smoking.
Use of the OMP involves a minimal surgical procedure with few side effects. Insertion of the OMP on gestational day (GD 1 ) 4, before embryos are implanted in the rat uterine wall, minimizes the potentially harmful effects of anesthesia on the developing embryo (e.g., failure to implant). Moreover, the gradual decrease in the pumping rate of the OMP minimizes withdrawal symptoms associated with abrupt termination, which may disrupt crucial maternal behavior immediately after birth (Vaglenova et al. 2008) . Overt signs of infection, skin necrosis, or other abnormalities have not been reported with this model (Slotkin et al. 1987; Sobrian et al. 1995) .
However, continuous nicotine infusion does not model either the intermittent bolus delivery of nicotine associated with smoking in humans (LeSage et al. 2006) or daily fl uctuations in nicotine serum levels seen in smokers (i.e., relatively constant levels of plasma nicotine concentration throughout waking hours with a gradual decline overnight, followed by increasing levels through the morning hours), which may afford some protection to the developing human fetus (Eppolito and Smith 2006; Levin et al. 1996; Lichtensteiger et al. 1988) . Moreover, the maintenance of a steady-state maternal plasma level of the drug enables the equilibrium of all fl uid compartments to the same fi nal concentration, thus compromising the protective role of the placenta (both human and rat placenta provide protection against nicotine by metabolizing a portion of the drug and by maintaining a phase delay between maternal and fetal circulation; Slotkin 1998). Furthermore, the increasing weight gain of the dam during gestation and the static infusion of the pump decrease the daily mg/kg dose of the drug as pregnancy progresses (Dwyer et al. 2009; Matta et al. 2007; Sobrian et al. 1995) . The continuous plasma levels of nicotine obtained with this model are more analogous to nicotine delivery via the patch, which has been recommended as a substitute for maternal smoking (Dwyer et al. 2009). 2007) or without saccharine or sucrose to mask the bitter taste (Murrin et al. 1987; Peters and Tang 1982; Peters 1984; Schneider et al. 2010; Sorenson et al. 1991) -in the dam's sole source of drinking water. This easy, noninvasive method of drug delivery has been touted as mimicking the voluntary nicotine consumption of humans (Paz et al. 2007 ). In addition, it avoids the stress of either multiple drug injections or exposure to a tobacco smoke-fi lled chamber (Peters and Tang 1982; Schneider et al. 2010) . Studies have reported that pregnant females ingest nicotine in drinking water at levels that provide nicotine intake and blood levels comparable to those of moderate and heavy smokers (Schneider et al. 2010) .
But this method is not without drawbacks. Bioavailability of orally administered nicotine is poor (approximately 45%)-nicotine has an extensive fi rst pass effect and much is metabolized by the liver before reaching the general circulation (Matta et al. 2007 ). More importantly, when nicotinelaced water is the sole drinking fl uid, rats reduce their water (and food) intake, preventing a steady-state concentration of nicotine (Murrin 1987) , producing dose-dependent nicotine consumption (Schneider et al. 2010) , and creating a risk of dehydration. Research indicates that water restriction during pregnancy induces marked changes in maternal-fetal fl uid homeostasis (Schneider et al. 2010) . Moreover, possible developmental effects of prenatal nicotine exposure cannot be conclusively distinguished from potential effects of dehydration and any associated vasoconstriction and hypoxia (Peters and Tang 1982; Schneider et al. 2010) .
There is also considerable variability in the daily amount of nicotine to which the fetus is exposed, with over a 4½-fold difference in daily intake reported among dams (Murrin et al. 1987) . In an effort to minimize the dehydration (and mild anorexia) produced by this route of nicotine administration, premating exposure for 2 to 4 weeks has been used to acclimate females to the drug and stabilize their food and water consumption. However, even at the lowest dose, when stabilized, the dams' liquid intake was half that of controls (Murrin et al. 1987) .
Exposure to Cigarette Smoke
Studies of the effects of cigarette smoke on pregnant rodents are limited. Although they are critical, as smoking is the primary human mode of nicotine delivery (Matta et al. 2007 ), they have not proven particularly feasible even with a noseonly smoking model (Carmines et al. 2003; Gaworski et al. 2004) . Humans may smoke intermittently over the course of 24 hours and may experience longer, more pronounced exposure to carbon monoxide and nicotine than can be accomplished in animal studies using a 1-hour twice-daily (Carmines et al. 2003) or once-daily 2-hour (Gaworski et al. 2004 ) whole body exposure to cigarette smoke in smoking chambers. In addition to vasoconstriction and hypoxia, dams show signs of overt toxicity-diarrhea, salivation, redness around the eyes (Carmines et al. 2004; Gaworski et al. 2004; Younoszai et al. 1969 )-and there is an increase in maternal deaths (Bertolini et al. 1982) . Furthermore, nose-only exposure models require restraint of the dam, which is a known stressor. Although the use of smoking chambers does not require restraint, this method causes irritation of air passages and some degree of hypoxia. Rats in these chambers also exhibit restlessness, dyspnea, wheezing, and sweating (Younoszai et al. 1969 ).
Doses and Maternal Plasma Levels
In determining the appropriate choice of dose in animal models of developmental nicotine exposure, pharmacokinetic differences between humans and various species are of paramount importance (see Matta et al. 2007 for extensive review). Doses in animals (mg/kg/day) should approximate plasma nicotine levels corresponding to those in humans who smoke either at a certain level (light, moderate, or heavy) or a specifi ed number of packs per day (e.g., ½ a pack, 1-2 packs, or 3-5 packs). In the United States today, one commercial-brand cigarette contains 10 mg or more of nicotine, and an average smoker inhales 1 to 2 mg of nicotine per cigarette (Vieira et al. 2010) . Table 1 lists 2 clinical and 14 experimental studies of developmental nicotine exposure that presented data on maternal plasma/serum levels of nicotine and/or cotinine. Doses below 2 mg/kg/day are consistently related to human smoking of a pack or less per day (Fung 1989; Murrin et al. 1987) or to levels immediately after smoking a cigarette (Sarasin et al. 2003) . Plasma levels of nicotine in dams from these three studies ranged from 20 to 50 ng/ml, which approximates venous nicotine concentrations in women who smoke one pack a day during pregnancy or wear the transdermal 21-mg nicotine patch (Oncken et al. 1997) . However, these values are higher than nicotine levels reported in human maternal venous serum and in the placenta at birth (Luck et al. 1985) . Moreover, these plasma levels overlap with those reported for doses of 2.0 to 3.5 mg/kg/day (Paz et al. 2006; Richardson and Tizabi 1994; Roy and Sabherwal 1994; Shacka et al. 1997 ) and even a 6 mg/kg/day dose (Slotkin et al. 2007) , which is equated with the 2 to 3 packs/day of a heavy smoker.
Daily mg/kg doses of nicotine delivered by OMP appear to produce more consistent levels at lower rather than higher doses. At doses of 3 or 6 mg/kg/day, plasma levels of nicotine can vary by an average factor of 5 (Richardson and Tizabi 1994; Slotkin et al. 2007a; Somm et al. 2008) . In general, at comparable doses, nicotine delivered through drinking water produces maternal plasma values that are lower than those produced by injection or OMP, while oral gavage markedly increases levels (Paulson et al. 1993 (Paulson et al. , 1994 .
In summary, maternal plasma levels in rodents produced by gestational exposure to nicotine by several routes of administration are generally higher than those reported in human smokers during pregnancy. Daily doses of nicotine at or below 2 mg/kg produce maternal plasma levels in rats comparable to those seen in pregnant women who smoke or wear the transdermal patch. This dose level in rats has been shown to produce neurobehavioral changes in the offspring without affecting their viability and growth, and to induce neuroanatomical and biochemical changes in the developing CNS (Navarro et al. 1989a; Sabherwal 1994, 1998; Roy et al. 2002) .
Effects on Offspring
Physical Effects
Birth Weight
Birth weight represents an accurate index of prenatal development, even when initial decrements are eventually recovered. As in humans, characteristics of nicotine teratogenicity in animal models include lower birth weight and decreased postnatal weight gain in offspring with or without recovery (Schneider 2010) . However, results are not consistent, even within laboratories, and studies have reported increases in fetal and postnatal growth as well as no effect. Table 2 summarizes the results of 56 studies that reported the effects of developmental nicotine exposure on birth weights and somatic development, as well as maternal and gestational variables (all the studies had "body weight" in the abstract or as a key term). Studies that report birth weight after prenatal or pre-and postnatal exposure to nicotine are equally likely to show no differences (Ajarem and Ahmad 1998; Bertolini et al. • 1982; Eppolito and Smith 2006; Eppolito et al. 2010; Franke et al. 2007; Fung 1988; Hamosh et al. 1979; Levin 1993; Navarro et al. 1989a; Paulson et al. 1993; Paz et al. 2006; Peters 1984; Peters and Ngan 1982; Peters and Tang 1982; Richardson and Tizabi 1994; Romero and Chen 2004; Segarra and Strand 1989; Sobrian et al. 1995 Sobrian et al. , 2003 Somm et al. 2008) or lower birth weight (Carmines et al. 2003; Cutler et al. • 1996; Gaworski et al. 2004; Holloway et al. 2005; Johns et al. 1982; LeSage et al. 2006; Martin and Becker 1971; Martin et al. 1976; Navarro et al. 1989a; Newman et al. 1999; Paulson et al. 1994; Peters 1984; Peters and Tang 1982; Roy and Sabherwal 1994; Schneider et al. 2010; Shacka et al. 1997; Sorenson et al. 1991; Vaglenova et al. 2004 Vaglenova et al. , 2008 Yanai et al. 1992 ).
When sexually dimorphic effects have been reported for birth weights, the decrease is preferentially seen in male offspring (Peters 1984; Peters and Tang 1982; Schneider et al. 2010) . In studies that measured fetal weights (Genedani et al. 1983; Hamosh et al. 1979; Navarro et al. 1989a,b; Zahalka et al. 1992) , few reported in utero growth retardation and decreased fetal weights (Carmines et al. 2003; Slotkin et al. 1986 Slotkin et al. , 1993 Younoszai et al. 1969 ). In contrast, Hamosh and colleagues (1979) reported that GD 20 fetuses exposed to nicotine were larger than control fetuses, but this difference was no longer evident at birth.
Differences in outcomes have been ascribed to different doses of nicotine (most of the cited studies used a dose of 1 to 6 mg/kg/day), different animal species and strains (Sprague-Dawley rats have been used in most of the animal models of developmental nicotine exposure), the age at which the dependent variables were measured, route of administration, or the developmental period of exposure. Analysis of the results shows that the latter two affect outcomes dramatically.
Prenatal exposure to nicotine via the osmotic minipump is least likely to result in lower birth weights. Eleven of the 22 studies shown in Table 2 reported no effect on birth weights; six reported defi cits, and one reported an increase (Hamosh et al. 1979) . Defi cits were not a function of daily dose as they occurred in the offspring of dams that received 2, 4, and 6 mg/kg/day of nicotine. Almost all studies in this group used Sprague-Dawley rats and a similar developmental exposure window.
Injection of nicotine to the pregnant dam produces more variable results. Seven of the studies shown in Table 2 reported decreased birth weights, and fi ve reported no defi cits. In addition to the various injection routes (s.c., i.p., or i.v.), the species and strain of rat as well as differing nicotine exposure windows (premating and/or prenatal) are variables that might account for the contrasting results.
Exposure to cigarette smoke or oral administration of nicotine are the methods most likely to result in offspring with reduced birth weights. The use of both premating and gestational nicotine exposure in drinking water resulted in lower birth weights in four (Peters 1984; Peters and Tang 1982; Schneider et al. 2010; Sorenson et al. 1991) of fi ve studies (Paz et al. 2007 ). Gavage produced a dose-related reduction in birth weights in two studies that used this method (Paulson et al. 1993 (Paulson et al. , 1994 . Exposure of the pregnant dam to either whole body or nose-only cigarette smoke consistently resulted in fetal growth retardation and doserelated decreases in birth weights (Bertolini et al. 1982; Carmines et al. 2003; Younoszai et al. 1969) .
Direct neonatal exposure (48 hours after birth) of pups to nicotine, by either gastric intubation (Gilbertson and Barron 2005; Girard et al. 2001; Huang et al. 2006; Thomas et al. 2000) or s.c. injection , resulted in an immediate decrease in body weight gain, although recovery began shortly after drug discontinuation. The immediate decreased growth in the oral gastric intubation model has been suggested as evidence that nicotine's effect on birth weight results from direct anorexic rather than indirect effects from placental dysfunction or increased fetal hypoxia (Huang et al. 2006) .
Combined pre-and neonatal exposure via osmotic minipump did not clearly produce an additive effect on offspring birth weights: three studies reported a decrease in birth weight (Newman et al. 1999; Vaglenova et al. 2004 Vaglenova et al. , 2008 ) and three did not ( Romero et al. 2004) . In contrast, the use of either the injection (s.c.) or smoking model for combined gestational and neonatal exposure to nicotine resulted in a consistent decrease in birth weight (Gaworski et al. 2004; Gospe et al. 1996; Holloway et al. 2005; Martin et al. 1976 ). Birth weight changes may refl ect alterations in maternal gestational weight gain. Nicotine, an anorexigenic drug, can decrease maternal food and water intake and thus alter nutritional status (Williams and Kanagasabai 1984) . Although most of the studies that include maternal body weight report lower maternal and fetal weight gain (Carmines et al. 2003; Cutler et al. 1996; Gaworski et al. 2004; Martin et al. 1976; Navarro et al. 1990; Paulson et al. 1994; Richardson and Tizabi 1994; Schneider et al. 2010; Slotkin et al. 1986 Slotkin et al. , 1993 Slotkin et al. , 1987 Younoszai et al. 1976) , others report either lower birth weights in the absence of maternal alteration in gestational weight gain Peters 1984; Roy and Sabherwal 1994; Vaglenova et al. 2004 Vaglenova et al. , 2008 or no signifi cant fetal/birth weight effects despite reductions in maternal weight gain (Bertolini et al. 1982; Navarro et al. 1989a; Paulson et al. 1993; Romero et al. 2004; Zahalka et al. 1992 ). Slotkin and colleagues (1986) suggested that it is unlikely that fetal growth retardation and lower birth weights are due solely to nicotine's adverse effects on maternal weight gain, as there is catch-up in fetal growth during the last week of gestation when defi cits in maternal weights are most evident.
Changes in gestational length, litter size, or maternal toxicity are generally not seen, except after maternal exposure to smoke (see Table 3 ). The lack of overt maternal toxicity and effects on intrauterine growth is consistent with the selectivity of effects of prenatal nicotine exposure on the developing nervous system (Navarro et al. 1989b) , rather than alterations in general measures of growth and development (Paulson et al. 1993) .
Postnatal Body Weight
Lower birth weights can result in lower postnatal weight gains and/or body weights. However, these effects were transient and occurred primarily during the preweaning period, with recovery reported during adolescence (Table 2; Hamosh et al. 1979; Paulson et al. 1994; Schneider et al. 2010; Slotkin et al. 1986 Slotkin et al. , 1987 Sorenson et al. 1991; Vaglenova et al. 2004 Vaglenova et al. , 2008 Yanai et al. 1992) .
But there are also reports of (1) no further changes in body weight after a decreased birth weight (Peters 1984; Peters and Tang 1982) and (2) decreases in body weight that appear at weaning (Shacka et al. 1997 ) and persist into adulthood (Gaworski et al. 2004) . Decrements in postnatal growth also occur in the absence of decreased birth weights. While recovery is again reported before weaning (Navarro et al. 1989a) or during adolescence (Ajarem and Ahmed 1998; Vaglenova et al. 2008; Xu et al. 2001) , decreases have persisted up to PND 60 (Eppolito and Smith 2006; Paulson et al. 1993 ). Yet other studies report no changes in body weight in rats between 6 and 14 months of age (Slotkin et al. 2007; Sobrian et al. 2003) .
Recent animal studies that parallel fi ndings in the clinical literature suggest that low birth weight may trigger weight gain or obesity during adolescence. Such weight gains are evident during the fi rst postnatal week and continue through the early postweaning period (Levin et al. 1993 Somm et al. 2008 ). In addition, Holloway and colleagues (2005) reported an increase in weight gain at 26 weeks as well as a long-term weight gain at 14 to 16 months of age. Similar weight gains, in the absence of differences at 2 to 4 months of age, have been reported at 14 months of age (Martin et al. 1976 ). Taken together, these studies indicate that nicotine-exposed offspring that were smaller at birth and before weaning were heavier in old age.
However, rats exhibit weight increases in both the absence (Levin et al. 1993; Somm et al. 2008 ) and presence Newman et al. 1999 ) of low birth weight, and normal weights by adolescence. This transient weight gain during the fi rst month after birth has been related to the increased weight gain seen in adult rats after withdrawal from chronic nicotine exposure (Levin et al. 1993 ) and may refl ect blunted sympathetic responsiveness (Levin 2005) , increased adipose tissue, and changes in glucose homeostasis and metabolic activity (Holloway et al. 2005; Somm et al. 2008 Somm et al. , 2009 .
In summary, results of animal studies indicate that prenatal exposure to nicotine does not consistently result in fetal growth retardation or decreased birth weight. When decreased birth weights occur, in many instances they are transient and recovery occurs before or during adolescence or early adulthood. In contrast, reports of increased weight gain indicate that they appear to be long-lasting and become evident at 6 and 14-16 months of age (no changes in body weight have been observed between 6 and 14 months). The route and developmental window of administration are the two variables that appear to contribute most to the disparate results reported for the effects of nicotine on offspring birth and body weight.
Physical and Refl ex Development
Maternal smoking during pregnancy has been linked to deficits in fi ne motor skills and auditory processing in human infants and toddlers (Ernst et al. 2001) . Similar defi cits in sensorimotor development have been reported in animal models of developmental nicotine exposure.
Refl ex behaviors and physical features are ontogenetic landmarks that refl ect integration and maturation in the CNS as well as the development of dynamic postural refl ex adjustments that in the rat involve the regulation of vestibular, exteroceptive (tactile), and proprioceptive systems. Alterations in the timing of their appearance could signal damage or poor development of motor and sensory systems in the brain, which might negatively affect later behavioral and cognitive ability (Sobrian et al. 1990; Vaglenova et al. 2008) . All studies in rats except as noted. For strain information, see Table 2 .
Mouse
Physical development. Eye opening, pinna detachment, and incisor eruption are most often assessed (Table 4) . With one exception (Schneider et al. 2010) , pinna detachment and incisor eruption (Gaworski et al. 2004; Martin et al. 1976; Paulson et al. 1993 Paulson et al. , 1994 Shacka et al. 1997 ) develop normally, but the appearance of fur is delayed (Ajarem and Ahmad 1998; Schneider et al. 2010) . Reports on the maturation of eye opening are mixed. Most studies report normal development (Gaworski et al. 2004; Martin et al. 1976; Paulson et al. 1993; Segarra and Strand 1989; Shacka et al. 1997) , but delayed or accelerated maturation is seen in models involving nicotine administration either orally (Girard et al. 2001; Paulson et al. 1994; Schneider et al. 2010) or by injection (Ajarem and Ahmad 1998) . Physical indices of sexual maturation (e.g., vaginal patency, testes descent) show either normal Paulson et al. 1993 Paulson et al. , 1994 or sex-dependent accelerated (Paulson et al. 1994 ) development.
Refl ex maturation. Various tasks have been used to measure sensorimotor function. With the exception of a single report of improved swimming development (Paulson et al. 1994) , studies report either delayed or normal development after pre-/postnatal exposure to nicotine. Negative geotaxis and surface righting are used to determine the degree of limb coordination and locomotor development; delayed development of these refl exes has been related to both retarded physical (limb/motor) development and neuronal incapacity (Abdel-Rahman et al. 2005) . Although reports often cite delays in surface righting, a vestibular reaction that depends largely on brainstem structures (Ajarem and Ahmad 1998; Altman et al. 1971; Paulson et al. 1993 Paulson et al. , 1994 Schneider et al. 2010; Vaglenova et al. 2008) , there are reports to the contrary (Fung 1988; Sobrian et al. 1995) ; moreover, aerial righting develops normally (Gaworski et al. 2004) . Half of the studies that measured negative geotaxis reported normal development (Fung 1988; LeSage et al. 2006; Paulson et al. 1993) , and the remainder a delay (Ajarem and Ahmad 1998; Schneider et al. 2010; Vaglenova et al. 2008) . Similar mixed results are reported for performance on the inclined plane (Adbel-Rahman et al. 2005; Abou-Donia et al. 2006 ) and for development of the auditory startle refl ex (Gaworski et al. 2004; Sobrian et al. 1995) . In contrast, cliff avoidance, a placing reaction dependent on cerebral maturation, develops normally (Ajarem and Ahmad 1998; Sobrian et al. 1995) .
Although most defi cits resolve during the preweaning period, some delays do not dissipate with age. Variability in results may be due to the use of different strains of rat, doses, and routes of administration of nicotine as well as differences in refl ex testing methods, so it is diffi cult to pinpoint the source(s) of variation. However, assessments appear to indicate that motor development is more affected than sensory function and that neonatal nicotine exposure (Girard et al. 2001) does not by itself delay refl ex development, whereas combined pre-and postnatal nicotine exposure does so consistently (Gaworski et al. 2004; Vaglenova et al. 2008) .
Sexual Differentiation
In the clinical literature, there is only one direct survey of maternal smoking and homosexuality. Using a database of over 7,500 humans, Ellis and Cole-Harding (2001) reported that prenatal nicotine signifi cantly increased the probability of lesbianism among female offspring, especially with fi rst trimester exposure. Gestational nicotine exposure did not seem to alter the incidence of human male homosexuality. Experimental support for such an outcome is provided by Smith and colleagues (2003) , who reported that gestational nicotine exposure increased plasma testosterone levels in 30-day-old female but not male rats. There are, however, reports that gestational stress can feminize both male rats (Velazquez-Moctezuma et al. 1993; Ward 1984) and humans (Dörner et al. 1980) , possibly due to endocrine suppression of masculinizing testosterone spikes that occur around the time of birth (Weinstock 2007) .
Because prenatal nicotine exposure has stresslike effects on the adrenal glands (Sarasin et al. 2003; von Ziegler et al. 1991) , it is theoretically possible that developmental nicotine exposure might feminize male sexual orientation and behavior. There is some support for this possibility in the experimental literature, which reports that gestational nicotine exposure reduces the important masculinizing GD 18 testosterone spike in fetal male rodents (Lichtensteiger and Schlumpf 1985; Sarasin et al. 2003) . Studies of nicotineexposed GD 18 males have shown lower levels of both proopiomelanocortin (POMC) messenger RNA in the anterior pituitary (Sarasin et al. 2003) and lower adult plasma testosterone levels (Segarra and Strand 1989) . Such effects in males may be accompanied by behavioral feminization/demasculinization of sexual performance (Segarra and Strand 1989) and saccharine preference (Lichtensteiger and Schlumpf 1985) , and may be mediated by gestational nicotine's feminization of male brain aromatase by PND 6 (von Ziegler et al. 1991) . Although these fi ndings suggest that gestational nicotine may feminize male rat sexual behavior, studies have reported little or no feminization of neonatal genitalia as measured by changes in the anogenital distance (Cutler et al. 1996; Gyekis et al. 2010b) .
Given the fi ndings of Ellis and Cole-Harding (2001) of increased lesbianism in nicotine-exposed human offspring, it is important to investigate developmental nicotine effects on both sexes and to conduct such studies in different laboratories. Such research may also demonstrate whether gestational nicotine exposure has other effects on sexual differentiation.
Behavioral Effects
We have identifi ed 33 studies reporting activity levels in rats (24) and mice (9) to assess the effects of developmental nicotine exposure (Table 5) . Some of the studies used multiple exposure periods, so tabulation by exposure period does not always total 33 in Table 5 ; 15 studies used exposure during gestation, 10 exposed dams or neonates at some point from birth until weaning, and 10 exposed animals both pre-and neonatally.
These studies do not reveal a clear pattern of effects. For all three exposure periods, 12 studies produced evidence for increased activity in nicotine-exposed rodents, 12 found reduced activity, and 20 reported no effect. These different outcomes do not appear to be dependent on the species, dose, sex, or age at the time of testing.
Looking at outcomes for male and female offspring for all studies and exposure periods, 12 studies found that males were hyperactive relative to controls (Ajarem and Ahmad 1998; Fung 1988; Newman et al. 1999; Paulson et al. 1994; Pauly et al. 2004; Paz et al. 2007; Peters et al. 1979; Richardson and Tizabi 1994; Schlumpf et al. 1988; Thomas et al. 2000; Tizabi et al. 2000; Vaglenova et al. 2004) , whereas 6 noted that they were hypoactive (Gilbertson and Barron 2005; Huang et al. 2007 ; King and Strand 1988; Peters and Tang 1982; Schlumpf et al. 1988) . With respect to female offspring, six of the studies reported that they were hyperactive (Fung 1988; Newman et al. 1999; Paulson et al. 1994; Paz et al. 2007; Peters et al. 1979; Thomas et al. 2000) and seven that they were hypoactive (Gilbertson and Barron 2005; Huang et al. 2007; King and Strand 1988; Pauly et al 2004; Romero and Chen 2004; Vaglenova et al. 2004 ).
Of studies that tested both males and females, only fi ve reported sex-specifi c differences (Pauly et al. 2004; Peters and Tang 1982; Romero and Chen 2004; Schlumpf et al. 1988; Vaglenova et al. 2004) ; the other 14 showed the same developmental nicotine effect-either hyper-or hypoactivityon both sexes. Even among the fi ve studies that showed differences, there were no clear trends: two reported that males but not females were hyperactive relative to controls (Pauly et al. 2004; Vaglenova et al. 2004) , one that males were hypoactive (Peters and Tang 1982) , and a fourth that males were both hyper-and hypoactive depending on their age at testing . Conversely, three of the fi ve studies found that females were hypoactive relative to controls (Pauly et al. 2004; Romero and Chen 2004; Vaglenova et al. 2004 ). Thus these data do not reveal sex-specifi c differences in the effects of nicotine exposure on offspring activity.
Age at testing also does not account for the variability in effects reported for early nicotine exposure on activity measures. Table 6 shows that testing before weaning, in adoles- cence, and in adulthood produced roughly the same proportions of fi ndings of enhanced or reduced activity. However, the data in this table suggest that effects on activity are more infrequent with increased age at time of testing. Thus 12 of 19 activity assessments conducted before weaning gave evidence of changes in activity in one direction or the other, 7 of 16 studies provided similar evidence when testing occurred during adolescence, and only 2 of 9 studies conducted during adulthood reported activity effects.
One source of the variability in these results may be the relatively brief exposures to open fi elds and other tests based on automated devices. It is well known that activity measures, especially very short-term activity measures, are confounded with anxiety-related freezing (Denenberg 1969) . The evidence presented in this review (see the section on Neuropsychiatric Effects) suggests that developmental nicotine exposure can enhance anxiety, which is an obvious confounding factor. Furthermore, different measures of activity, particularly running-wheel compared to open-fi eld activity, depend on different brain regions (Campbell and Lynch 1969) . Of the studies listed in Table 6 , only two used longterm exposure to the activity apparatus. Peters and Taub (1979) reported that in early adulthood both sexes were hyperactive only during the day with 24-hour exposure to an automated open fi eld, and the single residential runningwheel experiment found no nicotine exposure effects on adult male activity (Martin and Martin 1981) .
Thus the literature suggests that developmental nicotine exposure does not reliably affect activity levels and that, when it does, increased activity is seen as often as decreased activity. The literature also indicates that such effects are less frequently observed the greater the age at testing. Clearly these results discourage continuation of simple, brief activity measures in attempts to replicate human nicotine effects on ADHD. Replacement of short-term assessments with residential activity monitors such as the fi gure 8 maze or running-wheel experiments may provide less contradictory results.
Cognitive Effects
Epidemiological studies have linked human cognitive deficits to prenatal cigarette exposure. Although confounding variables may account for these defi cits, animal models have provided direct evidence that prenatal nicotine exposure produces subtle cognitive impairments that may be related to attention defi cits. Experimental studies show a large degree of heterogeneity not only in the measured outcomes but also with respect to dose, schedule, and route and developmental window of nicotine administration (Table 7) , but most report a performance defi cit in various aspects of cognitive tasks.
Defi cits are seen even in simple tasks such as spontaneous alternation (Johns et al. 1982 (Johns et al. , 1993 Levin et al. 1993) and spatial alternation in a T-maze . However, there are also reports of no effects of prenatal nicotine administration for both tasks (Huang et al. 2007; Sobrian et al. 1996) and even of improved performance (Levin et al. 1993) . Weanling rats prenatally exposed to nicotine showed a transient increase in the rate of spontaneous alternation at PND 22-30, which resolved into a defi cit by PND 35.
Trials to criterion for passive avoidance are similar in control rats and offspring exposed to combined gestational and neonatal exposure (Gaworski et al. 2004 ). However, increased errors to criterion and perseverative errors in reversal are reported in a 2-choice black-white discrimination task (Johns et al. 1982) as well as dose-related increases in run time and errors for an appetitive maze learning task (Peters and Ngan 1982) . Studies have also reported decreased effi ciency in appetitive operant tasks under several rein- Sources: (A1) Ajarem and Ahmad 1998; Fung 1988; Paulson et al. 1994; Pauly et al. 2004; Richardson and Tizabi 1994; Schlumpf et al. 1988; Vaglenova et al. 2004 . (A2) Thomas et al. 2000 . (A3) Newman et al. 1999; Paz et al. 2007; Peters et al. 1979; Tizabi et al. 2000 . (B1) Franke et al. 2007; Paulson et al. 1993; Peters and Tang 1982; Schlumpf et al. 1988; Shacka et al. 1997; Sobrian et al. 2003 Sobrian et al. , 2008 . (B2) Ankarberg et al. 2001 Ankarberg et al. , 2004 Eriksson et al. 2000; Fredriksson et al. 2000; Frischer et al. 1988; Gilbertson and Barron 2005; King and Strand 1988 . (B3) Chistyakov et al. 2010; Gaworski et al. 2004; Martin and Martin 1981; Newman et al. 1999; Romero and Chen 2004; Tizabi et al. 1997 . (C1) King and Strand 1988; LeSage et al. 2006; Pauly et al. 2004; Peters and Tang 1982; Schlumpf et al. 1988; Vaglenova et al. 2004 . ( forcement schedules (Franke et al. 2008; Martin and Becker 1971) . The conditioned avoidance response (CAR) involves intermediate complex association ability. The task requires an animal to return to a compartment where it has been negatively reinforced, which, in part, necessitates reversal learning. Deficits are seen in studies from all three exposure categories-prenatal, pre-and postnatal, and neonatal (Bertolini et al. 1982; Genedani et al. 1983; Peters and Ngan 1982; Vaglenova et al. 2008 ). Impaired acquisition rates (Genedani et al. 1983; Peters and Ngan 1982) and a decreased number of avoidances (Vaglenov et al. 2008 ) are seen in young adult (i.e., 60-to 75-day-old) and middle-aged (6-month-old) rats, indicative of an enduring defi cit. Sexually dimorphic effects are apparent at both ages, with females showing the greater impairment in young adulthood and males exhibiting decreased avoidance behavior at 6 months (Vaglenova et al. 2008) .
However, CAR learning was also enhanced in young adult offspring (Bertolini et al. 1982) , and researchers have reported that prenatal nicotine did not alter the number of animals reaching criteria or days to criteria (Bertolini et al. 1982; Paulson et al. 1993 Paulson et al. , 1994 . Confounds related to differences in shock sensitivity and activity levels may be responsible for the disparate results. Differential sensitivity to the aversive shock stimulus can alter motivational levels and affect the strength of the conditioning response; and differences in activity levels can confound the interpretation of results, as hyperactivity can result in enhanced performance. Reliable use of this task as a measure of an animal's learning ability requires demonstration that different treatment groups are equally sensitive to the aversive shock stimuli and that intertrial crossings are comparable.
The Morris water maze (MWM) and the 8-arm radial maze (RAM) are complex tasks that require animals to choose from more than one alternative. Whereas avoidance tasks involve nonspatial associations, the MWM and the RAM measure spatial learning and working memory, the latter of which uses new information, gained in a single testing session, and requires short-term memory retrieval. Reference memory, which is memory with fi xed components, can also be measured on probe trials in the MWM. Use of the RAM entails food deprivation, which may exert a stress on drug-exposed animals; the MWM provides a natural reward, but requires normal motor skills.
In the RAM, choice accuracy is decreased (Ankarberg et al. 2001; Levin et al. 1993 Levin et al. , 1996 Sorenson et al. 1991; Yanai et al. 1992) in most of the studies listed, although two reported no effect of prenatal nicotine on this variable (Cutler et al. 1996; Levin et al. 1993 ) and one reported improved performance in young adult males, which demonstrated an increase in choice accuracy (Levin et al. 1993) .
Results with the MWM are more confl icting. Investigators report that reference memory is both impaired (Ankarberg et al. 2001; Eppolito and Smith 2006; Girard et al. 2001) and unaltered (Cutler et al. 1996; Huang et al. 2007 ) by prenatal nicotine exposure. Similar confl icting fi ndings are reported for working memory (Cutler et al. 1996; Eppolito and Smith 2006; Girard et al. 2001; Huang et al. 2007; . The plethora of dependent variables and impaired motor skills may account for some of the variability in the results.
The fact that defi cits are found with both the MWM and RAM suggests that impairments in spatial learning may not be paradigm specifi c but instead represent a general impairment in spatially cued tasks of learning and memory.
In summary, a variety of tasks have been used to test both simple and complex learning abilities in offspring developmentally exposed to nicotine and the results, although not consistent, suggest a global rather than a specifi c impairment Fung 1988; Newman et al. 1999; Paulson et al. 1994; Richardson and Tizabi 1994; Schlumpf et al. 1988; Thomas et al. 2000 . (A2) Ajarem and Ahmad 1998; Paulson et al 1994; Pauly et al. 1994; Paz et al. 2007 . (A3) Peters and Taub 1979 . (B1) Frischer et al. 1988; Gaworski et al. 2004; King and Strand 1988; Newman et al. 1999; Paulson et al. 1993; Schlumpf et al. 1988; Shacka et al. 1997 . (B2) Ankarberg et al. 2001 Ankarberg et al. , 2004 Chistyakov et al. 2010; Eriksson et al. 2000; Franke et al. 2007; Fredriksson et al. 2000; Paulson et al. 1993; Pauly et al. 2004; Romero and Chen 2004 . (B3) Ankarberg et al. 2001 Ankarberg et al. , 2004 Eriksson et al. 2000; Fredriksson et al. 2000; Martin and Martin 1981; Sobrian et al. 2003 Sobrian et al. , 2008 . No effect on days to criterion (spatial delayed matching to place); no effect on distances traveled for cued testing Girard et al. 2001 PND 60 (M & F)
Oral: gastric intubation, 2 mg/kg in infant formula PND 1-7 Day 1: increased escape latencies, more thigmotactic behavior; no effect on probe trials Huang et al. 2007 Table 7 in learning and memory. However, combined pre-and neonatal nicotine exposure results in consistent cognitive defi cits as measured in simple tasks such as spontaneous alternation and 2-choice discrimination and reversal (Johns et al. 1993) , as well as the more complex conditioned avoidance response (Vaglenova et al. 2004 (Vaglenova et al. , 2008 , and in reference but not working memory as tested in the Morris water maze (Eppolito and Smith 2006) . Only performance on passive avoidance appears to be spared (Gaworski et al. 2004 ).
Response to Drug Challenge
Thirteen studies assessed the effects of drug challenges (predominantly nicotine) on rats (7 studies) or mice (6) exposed to nicotine early in development (Abreu-Villaça et al. 2004a; Ankarberg et al. 2001 Ankarberg et al. , 2004 Chistyakov et al. 2010; Eriksson et al. 2000; Fredriksson et al. 2000; Pauly et al. 2004; Seidler et al. 1992; Shacka et al. 1997; Slotkin et al. 2006; Sobrian et al. 2003 Sobrian et al. , 2008 Zbuzek and Chin 1994) . Six studies used only male offspring, another six used both sexes, and one did not specify the sex of animals. Prenatal exposure was most common (eight studies), fi ve studies used neonatal exposure, and two combined pre-and neonatal exposure.
Behavioral studies of drug challenge in developmentally nicotine-exposed offspring are diffi cult to interpret because they induce both hyper-and hyporesponsiveness to drug challenge. For example, ethanol challenges increase activity, and exposure to nicotine on PND 10 to 14 increased sensitivity to these ethanol effects . Likewise, nicotine-induced analgesia is greatly prolonged by prenatal nicotine exposure, but only after the fi rst 6 months of life (Zbuzek and Chin 1994) . In addition, prenatal nicotine exposure alters the response to a subsequent cocaine challenge in the elevated plus maze by increasing time spent in open arms and open arm entries, possibly a form of hyperresponsiveness to cocaine (Sobrian et al. 2003) . Nicotine challenge-induced hypothermia is reduced as a consequence of prenatal exposure to nicotine, but only in females (Pauly et al. 2004) . Last, social interactions are abnormally reduced by a nicotine challenge in mice exposed both pre-and neonatally to nicotine .
The effects of nicotine challenge on motor activity appear to be related to the dose administered during development. Four studies report a blunting of the excitatory effect of nicotine challenge on activity due to low doses of prenatal nicotine exposure (Ankarberg et al. 2001 (Ankarberg et al. , 2004 Sobrian et al. 2008) , and two others report the opposite effects after high doses of prenatal exposure (Shacka et al. 1997; Sobrian et al. 2008) . Interestingly, these studies either used only males (Ankarberg et al. 2001 (Ankarberg et al. , 2004 Eriksson et al. 2000; Sobrian et al. 2008) or found such effects in males but not females (Shacka et al. 1997) .
It should also be noted that these drug challenge studies were conducted mostly in adults; only one tested neonates (Shacka et al. 1997 Ankarberg et al. 2001 Ankarberg et al. , 2004 Chistyakov et al. 2010; Eriksson et al. 2000; Fredriksson et al. 2000; Sobrian et al. 2003 Sobrian et al. , 2008 Zbuzek and Chin 1994) .
The studies discussed above reveal that developmental nicotine exposure has potent effects on responses to drug challenges. Only two of the studies failed to fi nd such effects; in both cases, this failure was restricted to one sex (Pauly et al. 2004; Shacka et al. 1997) . Moreover, the results were obtained mostly in adults, at ages when developmental nicotine effects on activity are less evident, further highlighting the sensitivity of drug challenge paradigms. Thus drug challenges are sensitive tools for detecting consequences of early nicotine exposure. As yet, however, these studies provide no clear understanding of the mechanisms that produce such effects.
Neuropsychiatric Effects
As mentioned above, gestational exposure to cigarette smoke is highly correlated with the subsequent appearance of neuropsychiatric problems in human offspring. Although this correlation has received little attention in the experimental literature, the results are consistent and supportive of clinical fi ndings. Table 8 lists 11 studies that explored animal analogues of psychiatric conditions in offspring developmentally exposed to nicotine. It is evident that the differences in outcomes are dependent on the development window of nicotine exposure.
Depression and Anxiety
Prenatal nicotine administration leads to increased depressive behaviors as measured by learned helplessness, fear trace conditioning (Paz et al. 2007) , and anhedonia (Franke et al. 2008) . The decrease in anxiety-like behavior, as measured with the elevated plus maze, has been interpreted as indicative of increased risk-taking behavior (Ajarem and Ahmad 1998; Sobrian et al. 2003) . This effect remains evident at 12 months of age, whereas anhedonia is not seen in 14-month-old animals (Sobrian et al. 2003) . Unlike clinical fi ndings, there is no evidence of sexually dimorphic effects when both sexes are tested (Ajarem and Ahmad 1998; Paz et al. 2007; Sobrian et al. 2003) .
In contrast, combined gestational/neonatal nicotine exposure or neonatal administration alone results in increased anxiety (Eppolito et al. 2010; Gilbertson and Barron 2005; Gyekis et al. 2010a; Huang et al. 2007; Romero 2004; Vaglenova et al. 2004 Vaglenova et al. , 2008 and decreased risk-taking behavior (Gyekis et al. 2010a) . (We were unable to fi nd published studies that used animal analogues of depressive behavior with this exposure paradigm.) The appearance of increased anxiety is age dependent: it is not seen in the immediate postweaning period (Eppolito et al. 2010) or at 6 months of age (Vaglenova et al. 2008) but is evident in preweaning (Gilbertson and Barron 2005), adolescent (Huang et al. 2007; Vaglenova et al. 2004) , and adult (Eppolito et al. 2010; Huang et al. 2007; Vaglenova et al. 2008) offspring. In agreement with clinical fi ndings, male offspring displayed more anxiety-like behavior in three of the four studies that report sex differences (Eppolito et al. 2010; Gilbertson et al. 2005; Vaglenova et al. 2008) .
Taken together, the studies described show that the effects of developmental exposure to nicotine on the increased incidence of symptoms that model the psychiatric illnesses of anxiety and depression are remarkably consistent and independent of drug dose, species/strain of animal, and dependent variables measured. Their clear correlation with the developmental window in which nicotine is administered suggests that combined pre-/neonatal exposure provides the best translational model for determining the causal link and mechanism(s) responsible for the increased occurrence of psychiatric disorders after developmental exposure to nicotine.
Susceptibility to Drug Abuse
In humans, maternal smoking during pregnancy increases the likelihood that the nicotine-exposed offspring will also smoke, but the obvious and numerous confounds in this relationship require validation in animal models. Such studies are not numerous, but do suggest that in animals gestational nicotine exposure may enhance self-administration not only of nicotine but of cocaine and ethanol as well.
We found fi ve studies that demonstrated increased selfadministration of drugs of abuse-three with nicotine (Chistyakov et al. 2010; Klein et al. 2003; Levin et al. 2006) and one each with ethanol and cocaine (Franke et al. 2008) . We are unaware of any studies that report reductions in self-administration of any of these compounds by animals developmentally exposed to nicotine. Moreover, this increase in response rate appears to be limited to drugs of abuse, as gestational exposure to nicotine reduced bar pressing for sucrose pellets in adolescent male rats (Franke et al. 2008) .
Conditioned place preference (CPP) paradigms have been used to measure tolerance and sensitization to the reinforcing effects of drugs, with differing results. Paz and colleagues (2007) showed an increased preference for a location associated with cocaine administration in male and female rats exposed prenatally to nicotine, whereas four other studies provided no evidence of such effects for nicotine (Klein et al. 2003; Matta and Elberger 2007) , cocaine (Sobrian et al. 2003 ), or ethanol (Berger et al. 2010 in such offspring.
Of the fi ve studies that documented an increase in drug self-administration, four used male subjects (Chistyakov et al. 2010; Franke et al. 2008; Fredriksson et al. 2000; Klein et al. 2003) . The one using females (Levin et al. 2006) evaluated only nicotine self-administration, while those with males also included cocaine and ethanol. Similarly, of the four studies that detected no such effects, one (Klein et al. 2003 ) used only females and three used both sexes (Berger et al. 2010; Matta and Elberger 2007; Sobrian et al. 2003) .
Effects were evenly distributed across exposure periods: both prenatal exposure alone (Levin et al. 2006 ) and combined pre-and neonatal exposure (Chistyakov et al. 2010; Klein et al. 2003) increased nicotine self-administration. The single reports of enhanced self-administration of cocaine and ethanol followed pre-and neonatal exposure, respectively.
Although these data provide evidence of increased selfadministration of nicotine and other drugs of abuse in animals exposed developmentally to nicotine, the fi ndings of the CPP studies do not support the conclusion that it is due to enhanced reinforcing properties of the drugs as a result of developmental exposure to nicotine. Clearly, this is a topic that will reward further research.
Sex Differences
The clinical literature indicates sex differences in behavioral or physiological effects of early nicotine exposure, with ADHD and conduct disorders reported more often in males. Table 9 summarizes the presence or absence of sex effects for three measures with possible developmental nicotine effects: cognitive ability, activity, and body weight, the topics with the largest number of reports. The table includes only studies that reported data for both sexes. There were 60 such reports, providing information on possible sex differences on 102 measures; many papers reported more than one possible sex difference, using differing dependent variables or ages, with differences at some ages or on some dependent variables but not others.
As Table 9 shows, there are very few reports of sex differences in response to nicotine administered prenatally, neonatally, or both. Of the 57 positive fi ndings listed, 42 (74%) found no sex differences, and of the 11 that reported differences, results divided almost evenly between males and females as the more affected sex. Methodological issues may account for some of the discrepancies. Many studies simply pooled both sexes by litter and hence did not always provide compelling evidence for the presence or absence of sex differences in response to early nicotine exposure.
We hesitate to conclude that there is no real sex difference on a variety of measures as a consequence of developmental exposure to a range of nicotine doses, but it is certainly possible to deduce that evidence for such differences is scant. Future studies should include both sexes and test for possible sex differences in order to resolve this issue.
Mechanistic Considerations
The mechanisms by which developmental exposure to nicotine produces the behavioral abnormalities in animal models reviewed here are not clearly defi ned. Although developmental neurotoxicity is one causal mechanism linked to the cognitive defi cits seen with prenatal nicotine exposure, developmental neurotoxicity per se encompasses a variety of Sources: (A1) Vaglenova et al. 2008 . (A2) Peters and Tang 1982; Schlumpf et al. 1988 . (A3) Peters et al. 1979; Peters and Tang 1982; Peters 1984 . (B1) Eppolito and Smith 2006; Levin et al. 1996 . ( Johns et al. 1993; Smith et al. 1991; Sorenson et al. 1991; Vaglenova et al. 2004; Yanai et al. 1992 . (D2) Gilbertson and Barron 2005; Huang et al. 2007; King and Strand 1988; Newman et al. 1999; Paulson et al. 1994; Peters et al. 1979; Thomas et al. 2000 . (D3) Abreu-Villaça et al. 2004a; Ajarem and Ahmad 1998, Carmines et al. 2003; Cutler et al. 1996; Eppolito et al. 2010; Gaworski et al. 2004; Johns et al. 1982; King and Strand 1988; LeSage et al. 2006; Levin et al. 1996 Levin et al. , 2006 Lichtensteiger and Schlumpf 1985; Navarro et al. 1988 Navarro et al. , 1989 Newman et al. 1999; Paulson et al. 1993 Paulson et al. , 1994 Shacka et al. 1997; Slotkin et al. 1986 Slotkin et al. , 1990 Slotkin et al. , 1995 Slotkin et al. , 2010 Tizabi et al. 2000; Vaglenova et al. 2004 Vaglenova et al. , 2008 Xu et al. 2001; Yanai et al. 1992 . (E1) Gaworski et al. 2004; Huang et al. 2007; Paulson et al. 1993; Sobrian et al. 1995; Yanai et al. 1992 . (E2) Frischer et al. 1988; Gaworski et al 2004; Gilbertson and Barron 2005; King and Strand 1988; Newman et al. 1999; Paulson et al. 1993; Schlumpf et al. 1988; Shacka et al. 1997; Sobrian et al. 2003; Tizabi et al. 1997 .
(E3) Abdel-Rahman et al. 2005; Abreu-Villaça et al. 2004,b; Berger et al. 2010; Bertolini et al. 1982; Eppolito et al. 2010; Fewell et al. 2001; Fung 1988; Genedani et al. 1983; Girard et al. 2001; LeSage et al. 2006; Levin et al. 1993 Levin et al. , 1996 Levin et al. , 2006 Navarro et al. 1990; Pauly et al. 2004; Paz et al. 2007; Richardson and Tizabi 1994; Romero and Chen 2004; Roy and Sabherwal 1998; Roy et al. 2002; Schlumpf et al. 1988; Shacka et al. 1997; Slotkin et al. 1991; Sobrian et al. 1995 Sobrian et al. , 2003 Thomas et al. 2000; Tizabi et al. 2000; Xu et al. 2001. primary mechanisms (e.g., cell death) that can infl uence secondary and/or tertiary mechanisms that lead to functional abnormalities. We restrict our considerations to two families of mechanisms likely responsible in some part for the behavioral abnormalities caused by early nicotine exposure: (1) developmental reduction in neural cell number and (2) developmental effects on cholinergic neurotransmitter systems. 2 
Developmental Reduction in Neural Cell Number
There is little doubt that nicotine exposure early in development reduces the normal complement of nerve cells. Studies have shown that gestational or early postnatal nicotine exposure reduces the weight of the whole brain or of brain regions shortly after exposure cessation (Navarro et al. 1989a; Roy and Sabherwal 1994; Slotkin et al. 1986 Slotkin et al. , 1993 Xu et al. 2001) . 3 However, such weight reductions are typically not large and are no longer evident within days to weeks after nicotine withdrawal (Navarro et al. 1989a; Roy and Sabherwal 2 How early nicotine exposure induces nerve cell loss and neurotransmitter abnormalities is not well understood, and lies outside the scope of this review. 3 There is one report of an increase in neonatal hippocampal weight after gestational exposure to a relatively high dose of nicotine (6 mg/kg/day) (Abreu-Villaça et al. 2004b). , 1998 Slotkin et al. 1986 Slotkin et al. , 2007 Xu et al. 2001) . The limited size and duration of these effects may account for the failure of some studies to detect them (Gospe et al. 1996; Navarro et al. 1989b; Roy and Sabherwal 1998; Slotkin et al 1991; Zahalka et al. 1992) .
These transitory weight reductions in the CNS have been attributed in part to decreased nerve cell numbers. Early nicotine exposure has been reported to reduce numbers of cerebellar Purkinje cells (Abdel-Rahman et al. 2005; Abou-Donia et al. 2006) , nerve cells in the ventral tegmental area , and pyramidal cells in the somatosensory cortex (Roy et al. 2002) . We are aware of only one study that found no lasting effects on cell numbers almost 6 months after early exposure (Slotkin et al. 2007 ). Other indications of neuronal cell death after early nicotine exposure include reduced dendritic arborization and cell size (Roy and Sabherwal 1998) , increased cell density (Roy and Sabherwal 1994) , and increased mitotic fi gures and pyknotic cells .
Regional DNA concentration is a common measure of cellularity in the CNS. A number of studies have reported that DNA concentration or synthesis is suppressed by developmental nicotine exposure (Gospe et al. 1996; McFarland et al. 1991; Navarro et al. 1989b; Qiao et al. 2003; Slotkin et al. 1986 Slotkin et al. , 1987 Slotkin et al. , 2005 , providing perhaps the single most compelling evidence that nicotine can reduce cell numbers in the developing brain.
Studies also report a variety of neurochemical accompaniments of cell death or stress after early nicotine exposure.
Glial fi brillary acidic protein (GFAP), a marker for the astrocytic proliferation that usually accompanies cell death in nervous tissue, is elevated in the cerebellum of exposed rats (Abdel-Rahman et al. 2005; Abou-Donia et al. 2006) . Ornithine decarboxylase activity (ODC), which is also elevated as a result of nervous system insult, is increased in brain regions exposed to nicotine early in life (Navarro et al. 1989b; Slotkin et al. 1986 Slotkin et al. , 1991 Slotkin et al. , 1993 Smith et al. 1991) , as is c-Fos expression, which is elevated by brain injury (Slotkin et al. 1997; Trauth et al. 1999) .
Taken together, these studies demonstrate that early nicotine exposure reduces neuronal cell numbers and that such reductions are accompanied by, if not restricted to, actual neuronal cell death. Given the known correlation between brain size and cognitive abilities both within and across species, it is likely that these reductions account at least in part for the demonstrated reductions in cognitive performance reviewed here.
Developmental Effects on Cholinergic Neurotransmitter Systems
It has long been thought that acetylcholine (ACh) may play an important role in supporting neurogenesis and brain development, so it is also quite possible that alterations in this compound may reduce neuronal cell division and enhance nerve cell death. Because of technical diffi culties in directly and specifi cally labeling ACh-generating neurons, researchers have evaluated a variety of indirect measures of the functional status of brain cholinergic systems.
Studies of pre-or early postnatal nicotine exposure have identifi ed its clear effects on nicotinic receptors: it quickly desensitizes these receptors throughout the brain (Boyd 1987; Fenster et al. 1997; Lester and Dani 1995; Marks et al. 1993 Marks et al. , 2010 Ochoa et al. 1990; Papke et al. 2009; Vibat et al. 1995) , and this desensitization is followed by nicotinic receptor upregulation (Bhat et al. 1991; De Sarno and Giacobini 1989; Duncan et al. 2009; Flores et al. 1992; Gold et al. 2009; Govind et al. 2009; Moretti et al. 2010; Ortells and Barrantes 2010; Sanderson et al. 1993; Wecker et al. 2010; Wonnacott 1990; Xiao et al. 2009; Zambrano et al. 2009 ). These changes appear to be largely independent of age at exposure. Indeed, short-term changes in nicotinic receptor upregulation have been described at cessation of gestational nicotine exposure in late fetal monkeys (Slotkin et al. 2005) ; changes were most pronounced in α4 nicotinic receptors, less so in α7 receptors, and not observed in muscarinic receptor type 2.
Four studies have reported a lack of effect of gestational nicotine exposure on postnatal nicotinic ACh receptor binding (Abdel-Rahman et al. 2005; Abreu-Villaça et al. 2004; Slotkin et al. 2007a,b) . However, there is one report of a small but prolonged increase in the heteromeric α4 nicotinic receptor subtype (Slotkin et al. 2010) , and other studies have reported changes in the α7 homomeric nicotinic receptor involving decreases in 3 of 18 brain regions (Tizabi et al. 2000) as well as region-and sex-specifi c increases and decreases (Slotkin et al. 2004) .
Muscarinic sites have been less often evaluated, but with no more consistent results. One study showed that QNB (3-quinuclidinyl benzilate) binding density was increased in the rat hippocampus , another that M1 muscarinic receptor density was reduced in the striatum but not the hippocampus (Zahalka et al. 1993) , and a third that M2 but not M1 binding decreased in the brain stem . Results concerning the effects of developmental nicotine exposure on muscarinic receptors are too few to allow a meaningful conclusion.
Cholinergic receptors are expressed late in rodents' brain development, so the lack of clear effects of gestational nicotine exposure may be due to the lack of functional nicotinic receptors in early postnatal stages. Instead, early postnatal exposure (roughly equivalent to the third trimester in humans) produces more consistent results. Three studies report that such exposure reduces low-but not high-affi nity nicotinic receptor binding Miao et al. 1998; Nordberg et al. 1991) in rodent brain regions. Others have reported reductions in α7 nicotinic receptor sites in the brainstem and cerebellum but not the forebrain (Slotkin et al. 2004 ). The reduced low-affi nity binding may be due to a decrease in endogenous stimulation of receptors, suggesting that early prenatal nicotine exposure may reduce ACh release.
This possibility is enhanced by the results of studies that have combined gestational and early postnatal nicotine exposure. Combined exposure has been linked to a general reduction in nicotine binding in the prefrontal cortex, nucleus accumbens, substantia nigra, and ventral tegmental area as well as lower messenger RNA for α4 and α7 in the adult hippocampus and medial prefrontal cortex (Eppolito et al. 2010) .
In general, these data support the hypothesis that nicotine exposure during the equivalent of late human gestation may reduce nicotinic receptor numbers, a reduction perhaps accompanied by desensitization. These effects could be due to the actual death of cholinergic neurons, their target neurons, or both. Conversely, receptor alterations could occur in neurons still intact but functionally altered.
Studies of cholinergic neurotransmitter markers could assist in interpreting the results described above. Several studies have assessed brain choline acetyltransferase (ChAT) activity after gestational exposure to nicotine, with mixed results. Two studies reported reductions (Navarro et al. 1989a; Slotkin et al. 2007a) , one found an increase (AbreuVillaça et al. 2004) , and three others detected no changes (Slotkin et al. 2007b (Slotkin et al. , 2010 Zahalka et al. 1992 ). Abou-Donia and colleagues (2006) reported an elevation in acetylcholinesterase activity.
In contrast, reports of prenatal nicotine effects on the ACh reuptake site are more consistent: fi ve have noted reduced CNS hemicholinium 3 uptake sites (Abreu-Villaça et al. 2004; Navarro et al. 1989a; Slotkin et al. 2007a,b; Zahalka et al. 1992) , and only one the opposite outcome (Slotkin et al. 2010) .
The discussion of possible neurochemical mechanisms involved in the effects of developmental nicotine exposure has been limited to the cholinergic system. However, nicotinic cholinergic receptors are involved in the regulation of catecholaminergic function in the CNS and there is evidence that noradrenergic and dopaminergic synaptic transmissions also are adversely affected by fetal nicotine exposure (Navarro et al. 1988 (Navarro et al. , 1989b Seidler et al. 1992; Slotkin 1998) . The impact on these systems could mediate the behavioral effects of pre-and/or postnatal exposure to nicotine.
In summary, although the evidence indicates alterations in cholinergic systems after developmental exposure to nicotine, the divergent results do not permit strong conclusions. Still, the hemicholinium 3 uptake site studies and the neonatal exposure effects on nicotinic, cholinergic, and muscarinic receptors all suggest the possibility of neurotoxic effects of nicotine on ACh systems of the brain, predominantly during early postnatal development in the rat (corresponding to the third trimester in humans). It is impossible, though, to say precisely what brain areas are involved or whether there is delayed recovery.
Discussion and Summary
Overview of the Consequences of Animal Exposure to Nicotine
Prenatal exposure of the developing fetus to alcohol results in a specifi c pattern of altered growth, performance, and structure that constitutes fetal alcohol syndrome (Jones et al. 2010 ). In contrast, despite an extensive clinical and experimental literature, no consistent phenotype emerges as a result of gestational or developmental exposure to either cigarette smoke or nicotine. Epidemiological studies most often report low birth weight (and a subsequent risk of obesity), cognitive deficits, hypervigilance, an increased propensity to ADHD, conduct disorder, and psychiatric disorders in the children of mothers who smoked during pregnancy. However, these fi ndings are frequently complicated by confounding factors, which in some cases either statistically negate these results or are directly responsible for the effects attributed to maternal smoking during pregnancy. Moreover, formal attempts to replicate fi ndings are virtually nonexistent between laboratories and rare even within laboratories.
As our analysis of numerous experimental reports has shown, there appears to be no discernible pattern of nicotine effects in measures of activity, body weight, and sex differences. In contrast, measures of cognitive effects, response to drug challenges, psychiatric problems, and early physical and refl ex development are more consistent. Although none has achieved consensus outcome, reported effects generally correspond to those of human epidemiological studies.
The lack of consistent fi ndings compromises the face (and to some extent construct) validity of both animal and human models of developmental nicotine exposure. Until research produces clear, consistent outcomes, progress in understanding developmental nicotine effects will be halting or even nonexistent. The translational value of future studies with animal models will be enhanced only by greater attention to both the replicability of fi ndings (within and across laboratories) and the identifi cation and widespread use of more sensitive behavioral measures.
Statistical and Experimental Design Considerations
There is at least one explanation for the lack of consistency in reported effects on animals of developmental exposure to nicotine: the typical rodent experiment lacks the statistical power to reliably detect many of the effects seen in humans.
Prenatal smoking in humans is reported to cause about a half-standard-deviation drop in IQ (approximately 7 points) and the studies that produced these fi ndings used hundreds or thousands of subjects in both the nicotine-exposed and control groups. In contrast, the sample sizes in the typical rodent study in this area are frequently around 12 and seldom in excess of 20. Such sample sizes are inadequate for reliable detection of half-standard-deviation or other measurable differences in most reported effects. Table 10 shows sample sizes required per group (experimental and control) in a simple t-test to detect mean differences of half a standard deviation at a power of 0.80 (even this power guarantees a considerable percentage of failures to detect real differences of the sizes thought to be involved). Also tabulated is the actual statistical power attained with the typical sample size (N) of 12 rodents per group, or a relatively larger N of 20 per group. It is evident that traditional sample sizes in rodent experiments are inadequate for reliably detecting prenatal nicotine effects on human body weight or IQ. This is certainly one plausible explanation for the large number of rodent studies that fail to duplicate probable effects of gestational cigarette exposure in humans. Another problem in the animal studies reviewed here is a not infrequent failure to use the litter as the unit of statistical analysis (Holson and Pearce 1992) , resulting in sample size infl ation, with statistical signifi cance tests conducted with several or even all pups per litter. Sample size infl ation in turn causes alpha infl ation, a problem opposite to the power considerations described above. The degree of alpha infl ation-as much as threefold-depends on both the magnitude of litter differences and the number of pups used per litter (Holson et al. 2008) . Alpha infl ation is particularly common in studies that include both sexes; it is therefore important to remember that sex should be treated as a correlated measure within litter, not as an independent variable. Regrettably, the correct use of litter as the unit of analysis further reduces statistical power. The only recourse is to use larger sample sizes in rodent studies.
Finally, replication in experimental design is also associated with statistical problems. Such problems are seldom encountered in the literature as it is virtually unheard of for investigators to conduct multiple replications of experiments. As this survey reveals, this is a serious oversight. Should such designs be attempted, replicates must be treated as a random, not fi xed, effect. Statistical analysis of the significance of replicate effects then uses the treatment by replicate interaction as the error term, resulting in very low degrees of freedom and consequently low statistical power.
Approaches to Improve Assessment of Dependent Variables
Several measures may advance animal experiments on the consequences of developmental nicotine exposure and promote the replication of results, which can corroborate the effi cacy of a given treatment regime.
Studies should routinely include simple outcome measures as well as the tracking and reporting of offspring body weight and sex in addition to the assessment of physical features and refl ex development sensitive to nicotine. Evaluation of maternal behavior may also provide early indications of adverse effects of prenatal nicotine exposure.
Improvements are also possible with respect to the dependent variable most often measured: levels of activity. Typical attempts to measure activity are confounded by anxiety in the animals. Efforts to detect an ADHD-like effect of developmental nicotine exposure in animals require longterm evaluations of their activity in familiar environments, possibly including the presence of familiar cage-or littermates. The inclusion of positive control groups is advantageous in determining the possible CNS mechanisms responsible for behavioral alterations.
One fi nal problem-and opportunity-is the current lack of any substantive efforts to assess the impact of developmental nicotine exposure on social interactions. The effective use of animal models to study probable human developmental nicotine effects will require the development of social interaction measures to model human conduct disorder. Such measurements will not be easy but will certainly provide an exciting and potentially important opportunity to develop animal models of human conduct disorders that result from developmental nicotine exposure and other drugrelated causes.
